Ladenburg Thalmann Financial Services’s OncoSec Medical Incorporated ONCS Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-18	Closed	-$1K	–	5707
2019 Q3	$1K	Hold	18	–	–	﹤0.01%	5237
2019 Q2	$1K	Hold	18	–	–	﹤0.01%	5234
2019 Q1	$2K	Hold	18	–	–	﹤0.01%	5018
2018 Q4	$3K	Sell	18 -6	-25%	-$1.51K	﹤0.01%	4849
2018 Q3	$7K	Hold	24	–	–	﹤0.01%	4490
2018 Q2	$10K	Hold	24	–	–	﹤0.01%	4269
2018 Q1	$10K	Buy	24 +18	+300%	+$7.39K	﹤0.01%	4269
2017 Q4	$2K	Buy	+6	New	+$2.1K	﹤0.01%	4843

Other funds holding ONCS

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Salzhauer Michael $292M AUM 30% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ONCS Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services sold out of OncoSec Medical Incorporated (ONCS) in Q4 2019, closing a stake of 18 shares — an estimated $1K sold.

Ladenburg Thalmann Financial Services first reported a position in ONCS in Q4 2017 and held it in 8 quarters. The position peaked at $10K in Q2 2018. 20 funds tracked by Wall St. Rank hold ONCS as of Q4 2019.

Ladenburg Thalmann Financial Services reported no remaining OncoSec Medical Incorporated position as of Q4 2019 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 18 OncoSec Medical Incorporated shares in Q4 2019, an estimated $1K.
Ladenburg Thalmann Financial Services first reported a position in OncoSec Medical Incorporated in Q4 2017 and held it in 8 quarters.
Ladenburg Thalmann Financial Services's OncoSec Medical Incorporated position peaked at $10K in Q2 2018.
20 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.